These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
126 related articles for article (PubMed ID: 11555675)
1. Specific deficiency in nuclear factor-kappaB activation in neurons of the central nervous system. Jarosinski KW; Whitney LW; Massa PT Lab Invest; 2001 Sep; 81(9):1275-88. PubMed ID: 11555675 [TBL] [Abstract][Full Text] [Related]
3. Suppression of constitutive and tumor necrosis factor alpha-induced nuclear factor (NF)-kappaB activation and induction of apoptosis by apigenin in human prostate carcinoma PC-3 cells: correlation with down-regulation of NF-kappaB-responsive genes. Shukla S; Gupta S Clin Cancer Res; 2004 May; 10(9):3169-78. PubMed ID: 15131058 [TBL] [Abstract][Full Text] [Related]
4. Identification of a p65 peptide that selectively inhibits NF-kappa B activation induced by various inflammatory stimuli and its role in down-regulation of NF-kappaB-mediated gene expression and up-regulation of apoptosis. Takada Y; Singh S; Aggarwal BB J Biol Chem; 2004 Apr; 279(15):15096-104. PubMed ID: 14711835 [TBL] [Abstract][Full Text] [Related]
5. alpha-melanocyte-stimulating hormone inhibits NF-kappaB activation and IkappaBalpha degradation in human glioma cells and in experimental brain inflammation. Ichiyama T; Zhao H; Catania A; Furukawa S; Lipton JM Exp Neurol; 1999 Jun; 157(2):359-65. PubMed ID: 10364447 [TBL] [Abstract][Full Text] [Related]
6. The host environment promotes the constitutive activation of nuclear factor-kappaB and proinflammatory cytokine expression during metastatic tumor progression of murine squamous cell carcinoma. Dong G; Chen Z; Kato T; Van Waes C Cancer Res; 1999 Jul; 59(14):3495-504. PubMed ID: 10416616 [TBL] [Abstract][Full Text] [Related]
8. An anti-rheumatic agent T-614 inhibits NF-kappaB activation in LPS- and TNF-alpha-stimulated THP-1 cells without interfering with IkappaBalpha degradation. Aikawa Y; Yamamoto M; Yamamoto T; Morimoto K; Tanaka K Inflamm Res; 2002 Apr; 51(4):188-94. PubMed ID: 12058956 [TBL] [Abstract][Full Text] [Related]
9. Transformation nonresponsive cells owe their resistance to lack of p65/nuclear factor-kappaB activation. Hsu TC; Nair R; Tulsian P; Camalier CE; Hegamyer GA; Young MR; Colburn NH Cancer Res; 2001 May; 61(10):4160-8. PubMed ID: 11358840 [TBL] [Abstract][Full Text] [Related]
10. IkappaBalpha deficiency results in a sustained NF-kappaB response and severe widespread dermatitis in mice. Klement JF; Rice NR; Car BD; Abbondanzo SJ; Powers GD; Bhatt PH; Chen CH; Rosen CA; Stewart CL Mol Cell Biol; 1996 May; 16(5):2341-9. PubMed ID: 8628301 [TBL] [Abstract][Full Text] [Related]
11. Multi-parameter analysis of the kinetics of NF-kappaB signalling and transcription in single living cells. Nelson G; Paraoan L; Spiller DG; Wilde GJ; Browne MA; Djali PK; Unitt JF; Sullivan E; Floettmann E; White MR J Cell Sci; 2002 Mar; 115(Pt 6):1137-48. PubMed ID: 11884514 [TBL] [Abstract][Full Text] [Related]
12. Isodeoxyelephantopin, a novel sesquiterpene lactone, potentiates apoptosis, inhibits invasion, and abolishes osteoclastogenesis through suppression of nuclear factor-kappaB (nf-kappaB) activation and nf-kappaB-regulated gene expression. Ichikawa H; Nair MS; Takada Y; Sheeja DB; Kumar MA; Oommen OV; Aggarwal BB Clin Cancer Res; 2006 Oct; 12(19):5910-8. PubMed ID: 17021000 [TBL] [Abstract][Full Text] [Related]
13. Angiotensin II activates nuclear transcription factor kappaB through AT(1) and AT(2) in vascular smooth muscle cells: molecular mechanisms. Ruiz-Ortega M; Lorenzo O; Rupérez M; König S; Wittig B; Egido J Circ Res; 2000 Jun; 86(12):1266-72. PubMed ID: 10864918 [TBL] [Abstract][Full Text] [Related]
14. Nuclear retention of IkappaBalpha protects it from signal-induced degradation and inhibits nuclear factor kappaB transcriptional activation. Rodriguez MS; Thompson J; Hay RT; Dargemont C J Biol Chem; 1999 Mar; 274(13):9108-15. PubMed ID: 10085161 [TBL] [Abstract][Full Text] [Related]
15. Role of IkappaBalpha and IkappaBbeta in the biphasic nuclear translocation of NF-kappaB in TNFalpha-stimulated astrocytes and in neuroblastoma cells. Kemler I; Fontana A Glia; 1999 May; 26(3):212-20. PubMed ID: 10340762 [TBL] [Abstract][Full Text] [Related]
16. Cryptopleurine targets NF-κB pathway, leading to inhibition of gene products associated with cell survival, proliferation, invasion, and angiogenesis. Jin HR; Jin SZ; Cai XF; Li D; Wu X; Nan JX; Lee JJ; Jin X PLoS One; 2012; 7(6):e40355. PubMed ID: 22768286 [TBL] [Abstract][Full Text] [Related]
17. The inhibition of LPS-induced production of inflammatory cytokines by HSP70 involves inactivation of the NF-kappaB pathway but not the MAPK pathways. Shi Y; Tu Z; Tang D; Zhang H; Liu M; Wang K; Calderwood SK; Xiao X Shock; 2006 Sep; 26(3):277-84. PubMed ID: 16912653 [TBL] [Abstract][Full Text] [Related]
18. Genetic deletion of glycogen synthase kinase-3beta abrogates activation of IkappaBalpha kinase, JNK, Akt, and p44/p42 MAPK but potentiates apoptosis induced by tumor necrosis factor. Takada Y; Fang X; Jamaluddin MS; Boyd DD; Aggarwal BB J Biol Chem; 2004 Sep; 279(38):39541-54. PubMed ID: 15252041 [TBL] [Abstract][Full Text] [Related]